Australian Statistics on Medicines 2011
Table 1 - Musculo Skeletal System
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
MUSCULO-SKELETAL SYSTEM |
|||||||
M01AB05 |
DICLOFENAC |
||||||
P |
1299J |
Tablet 25mg (enteric coated) |
0.10 |
GM |
71,607 |
891,172 |
|
P |
1300K |
Tablet 50mg (enteric coated) 50 |
0.10 |
GM |
807,472 |
8,730,212 |
|
P |
1302M |
Suppository 100mg 40 |
0.10 |
GM |
13,903 |
334,612 |
|
A |
16918 |
Tablet 25mg 20 |
0.10 |
GM |
9,695 |
- |
|
A |
16971 |
Tablet 25mg 10 |
0.10 |
GM |
1,565 |
- |
|
A |
17454 |
Tablet 25mg 30 |
0.10 |
GM |
11,486 |
- |
|
A |
18567 |
Tablet 50mg 20 |
0.10 |
GM |
142,621 |
- |
|
A |
18726 |
Suppository 50mg 10 |
0.10 |
GM |
1,430 |
- |
|
A |
20662 |
Tablet 25mg (enteric coated) 30 |
0.10 |
GM |
2,281 |
- |
|
A |
20718 |
Tablet 25mg 30 |
0.10 |
GM |
1,721 |
- |
|
P |
5077F |
Tablet 50mg (enteric coated) |
0.10 |
GM |
1,630 |
16,158 |
|
P |
5361E |
Tablet 25mg (enteric coated) 100 |
0.10 |
GM |
113 |
1,441 |
|
P |
5362F |
Tablet 50mg (enteric coated) 50 |
0.10 |
GM |
1,175 |
14,593 |
|
P |
5365J |
Tablet 50mg (enteric coated) 50 |
0.10 |
GM |
847 |
9,779 |
|
M01AB55 |
DICLOFENAC with MISOPROSTOL |
||||||
P |
4190M |
Tablet 50mg 200ug 60 |
- |
- |
1,018 |
39,744 |
|
M01AB01 |
INDOMETHACIN |
||||||
P |
2454E |
Capsule 25mg |
0.10 |
GM |
293,848 |
3,432,413 |
|
P |
2757D |
Suppository 100mg |
0.10 |
GM |
51,720 |
1,125,151 |
|
P |
5377B |
Capsule 25mg 100 |
0.10 |
GM |
342 |
4,001 |
|
P |
5379D |
Capsule 25mg 100 |
0.10 |
GM |
292 |
3,428 |
|
M01AB15 |
KETOROLAC |
||||||
A |
13986 |
Ampoule 30mg per 1mL 5 |
30.00 |
MG |
2,400 |
- |
|
A |
14188 |
Tablet 10mg 30 |
30.00 |
MG |
1,985 |
- |
|
A |
14950 |
Ampoule 10mg per 1mL |
30.00 |
MG |
119 |
- |
|
M01AB02 |
SULINDAC |
||||||
P |
2047R |
Tablet 100mg |
0.40 |
GM |
1,737 |
27,812 |
|
P |
2048T |
Tablet 200mg |
0.40 |
GM |
4,981 |
76,119 |
|
P |
5217N |
Tablet 100mg |
0.40 |
GM |
819 |
- |
|
P |
5218P |
Tablet 200mg |
0.40 |
GM |
2,199 |
15 |
|
OXICAMS |
|||||||
M01AC06 |
MELOXICAM |
||||||
P |
8561N |
Tablet 7.5mg |
15.00 |
MG |
295,834 |
5,418,563 |
|
P |
8562P |
Tablet 15mg |
15.00 |
MG |
833,659 |
19,808,926 |
|
P |
8887R |
Capsule 7.5mg 30 |
15.00 |
MG |
373,397 |
6,851,257 |
|
P |
8888T |
Capsule 15mg 30 |
15.00 |
MG |
822,119 |
19,547,982 |
|
M01AC01 |
PIROXICAM |
||||||
P |
1895R |
Dispersible tablet 10mg 50 |
20.00 |
MG |
3,298 |
40,014 |
|
P |
1896T |
Dispersible tablet 20mg 25 |
20.00 |
MG |
50,143 |
597,909 |
|
P |
1897W |
Capsule 10mg |
20.00 |
MG |
22,410 |
273,518 |
|
P |
1898X |
Capsule 20mg |
20.00 |
MG |
108,078 |
1,287,711 |
|
ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS |
|||||||
P |
5203W |
Capsule 10mg |
20.00 |
MG |
262 |
2,958 |
|
P |
5204X |
Capsule 20mg |
20.00 |
MG |
206 |
2,454 |
|
PROPIONIC ACID DERIVATIVES |
|||||||
M01AE01 |
IBUPROFEN |
||||||
A |
13267 |
Tablet 200mg 12 |
1.20 |
GM |
267 |
- |
|
A |
13268 |
Tablet 200mg 24 |
1.20 |
GM |
3,636 |
- |
|
A |
13372 |
Tablet 200mg 48 |
1.20 |
GM |
2,384 |
- |
|
A |
15401 |
Susp 0.1/5mL 100mL |
1.20 |
GM |
420 |
- |
|
A |
21048 |
Tablet 200mg 50 |
1.20 |
GM |
3,002 |
- |
|
A |
21412 |
Tablet 400mg 12 |
1.20 |
GM |
259 |
- |
|
A |
21413 |
Tablet 400mg 24 |
1.20 |
GM |
962 |
- |
|
A |
21414 |
Tablet 400mg 10 |
1.20 |
GM |
203 |
- |
|
P |
3190X |
Tablet 400mg |
1.20 |
GM |
183,869 |
2,652,488 |
|
P |
3192B |
Tablet 400mg 30 |
1.20 |
GM |
224,118 |
2,061,146 |
|
P |
5123P |
Tablet 400mg |
1.20 |
GM |
399 |
4,311 |
|
P |
5124Q |
Tablet 400mg 30 |
1.20 |
GM |
8,218 |
74,808 |
|
P |
5368M |
Tablet 400mg 100 |
1.20 |
GM |
475 |
8,619 |
|
M01AE51 |
IBUPROFEN with CODEINE |
||||||
A |
17716 |
Tablet 200mg/12.8mg 48 |
- |
- |
1,699 |
- |
|
A |
18882 |
Tablet 200mg/12.8mg 48 |
- |
- |
324 |
- |
|
A |
18887 |
Tablet 200mg/12.8mg 48 |
- |
- |
275 |
- |
|
A |
19136 |
Tablet 200mg/12.5mg 12 |
- |
- |
5,141 |
- |
|
A |
19137 |
Tablet 200mg/12.5mg 12 |
- |
- |
18,233 |
- |
|
A |
19138 |
Tablet 200mg/12.5mg 12 |
- |
- |
3,014 |
- |
|
A |
19795 |
Tablet 200mg/12.8mg 75 |
- |
- |
1,231 |
- |
|
A |
20613 |
Tablet 200mg/12.8mg 48 |
- |
- |
258 |
- |
|
A |
21001 |
Tablet 200mg/12.5mg 15 |
- |
- |
1,761 |
- |
|
A |
21002 |
Tablet 200mg/12.5mg 30 |
- |
- |
42,944 |
- |
|
A |
21099 |
Tablet 200mg/12.8mg 30 |
- |
- |
50,265 |
- |
|
A |
21114 |
Tablet 200mg/12.8mg 30 |
- |
- |
19,505 |
- |
|
A |
21115 |
Tablet 200mg/12.8mg 24 |
- |
- |
174 |
- |
|
A |
21127 |
Tablet 200mg/12.8mg 24 |
- |
- |
390 |
- |
|
A |
21135 |
Tablet 200mg/12.8mg 24 |
- |
- |
381 |
- |
|
A |
21376 |
Tablet 200mg/12.8mg 24 |
- |
- |
403 |
- |
|
M01AE03 |
KETOPROFEN |
||||||
P |
1588N |
Suppository 100mg |
0.15 |
GM |
1,709 |
43,097 |
|
P |
1590Q |
Capsules 200mg (sustained release) 28 |
0.15 |
GM |
124,545 |
2,382,717 |
|
P |
5136H |
Capsule 200mg (sustained release) |
0.15 |
GM |
236 |
4,283 |
|
M01AE02 |
NAPROXEN |
||||||
A |
11401 |
Tablet 275mg 12 |
0.50 |
GM |
958 |
- |
|
P |
1614Y |
Tablet 750mg (sustained release) 28 |
0.50 |
GM |
101,532 |
1,225,225 |
|
P |
1615B |
Tablet 1g (sustained release) 28 |
0.50 |
GM |
215,496 |
3,006,352 |
|
P |
1658G |
Oral suspension 125mg per 5mL 474mL |
0.50 |
GM |
773 |
63,802 |
|
ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS |
|||||||
P |
1659H |
Tablet 500mg |
0.50 |
GM |
169,968 |
2,135,301 |
|
P |
1674D |
Tablet 250mg |
0.50 |
GM |
47,622 |
608,562 |
|
P |
1795L |
Tablet 550mg 50 |
0.50 |
GM |
37,543 |
478,248 |
|
P |
5176K |
Tablet 250mg |
0.50 |
GM |
140 |
1,357 |
|
P |
5177L |
Tablet 500mg |
0.50 |
GM |
291 |
3,559 |
|
P |
5346J |
Tablet 500mg 50 |
0.50 |
GM |
249 |
3,166 |
|
P |
5347K |
Tablet 750mg (sustained release) 28 |
0.50 |
GM |
340 |
4,224 |
|
P |
5348L |
Tablet 1g (sustained release) 28 |
0.50 |
GM |
213 |
3,229 |
|
P |
5349M |
Tablet 250mg 100 |
0.50 |
GM |
152 |
1,446 |
|
P |
5350N |
Tablet 500mg 50 |
0.50 |
GM |
111 |
1,380 |
|
P |
5397C |
Oral suspension 125mg per 5mL 474mL |
0.50 |
GM |
272 |
21,210 |
|
M01AE11 |
TIAPROFENIC ACID |
||||||
P |
2103Q |
Tablet 300mg |
600.00 |
MG |
8,140 |
142,779 |
|
FENAMATES |
|||||||
M01AG01 |
MEFENAMIC ACID |
||||||
A |
11611 |
Capsule 250mg 20 |
1.00 |
GM |
1,079 |
- |
|
P |
1824B |
Capsule 250mg |
1.00 |
GM |
46,048 |
833,514 |
|
COXIBS |
|||||||
M01AH01 |
CELECOXIB |
||||||
A |
17093 |
Capsule 200mg 10 |
0.20 |
GM |
5,064 |
- |
|
P |
8439E |
Capsule 100mg 60 |
0.20 |
GM |
238,573 |
7,659,158 |
|
P |
8440F |
Capsule 200mg 60 |
0.20 |
GM |
1,256,674 |
41,439,420 |
|
M01AH05 |
ETORICOXIB |
||||||
A |
20525 |
Tablet 30mg 30 |
60.00 |
MG |
4,188 |
- |
|
A |
20526 |
Tablet 60mg 30 |
60.00 |
MG |
7,797 |
- |
|
A |
20527 |
Tablet 120mg 10 |
60.00 |
MG |
5,414 |
- |
|
OTHER ANTIINFL./ANTIRHEUMATIC AGENTS, NON-STEROIDS |
|||||||
M01AX12 |
PENTOSAN-POLY SULFATE SODIUM |
||||||
A |
14955 |
Capsule 100mg 100 |
- |
- |
393 |
- |
|
SPECIFIC ANTIRHEUMATIC AGENTS |
|||||||
GOLD PREPARATIONS |
|||||||
M01CB03 |
AURANOFIN |
||||||
P |
1095P |
Tablet 3mg |
6.00 |
MG |
2,269 |
147,883 |
|
M01CB01 |
SODIUM AUROTHIOMALATE |
||||||
P |
2016D |
Injection 10mg |
2.40 |
MG |
115 |
7,599 |
|
P |
2017E |
Injection 20mg |
2.40 |
MG |
222 |
22,757 |
|
P |
2018F |
Injection 50mg |
2.40 |
MG |
1,377 |
209,816 |
|
PENICILLAMINE |
|||||||
M01CC01 |
PENICILLAMINE |
||||||
P |
2721F |
Tablet 125mg |
0.50 |
GM |
353 |
12,589 |
|
P |
2838J |
Tablet 250mg |
0.50 |
GM |
3,748 |
196,267 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
MUSCULO-SKELETAL SYSTEM |
|||||||
M02AA15 |
DICLOFENAC |
||||||
A |
14860 |
Gel 50g 1 |
- |
- |
3,417 |
- |
|
A |
14861 |
Gel 100g 1 |
- |
- |
11,872 |
- |
|
A |
14979 |
Gel 20g 1 |
- |
- |
1,164 |
- |
|
M02AA07 |
PIROXICAM |
||||||
A |
15090 |
Gel 0.5% 25g 1 |
- |
- |
344 |
- |
|
A |
15091 |
Gel 0.5% 50g 1 |
- |
- |
876 |
- |
|
CAPSAICIN and SIMILAR AGENTS |
|||||||
M02AB |
CAPSAICIN |
||||||
A |
15579 |
Cream 0.025% 45g |
- |
- |
153 |
- |
|
PREPARATIONS with SALICYLIC ACID DERIVATIVES |
|||||||
M02AC |
METHYL SALICYLATE |
||||||
A |
12931 |
Cream 100g 1 |
- |
- |
425 |
- |
|
P |
4022Q |
Compound Cream APF 100gm |
- |
- |
2,083 |
29,888 |
|
P |
4023R |
Ointment BP 100gm |
- |
- |
1,011 |
12,424 |
|
P |
4026X |
Liniment APF 100gm |
- |
- |
1,155 |
11,532 |
|
M02AC |
METHYL SALICYLATE with MENTHOL with EUCALYPTUS OIL |
||||||
A |
11224 |
Cream 125g 1 |
- |
- |
6,971 |
- |
|
A |
12943 |
Cream 50g 1 |
- |
- |
263 |
- |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
MUSCULO-SKELETAL SYSTEM |
|||||||
M03BC01 |
ORPHENADRINE CITRATE |
||||||
A |
11353 |
Tablet 100mg 100 |
0.12 |
GM |
9,503 |
- |
|
M03BC51 |
ORPHENADRINE CITRATE with PARACETAMOL |
||||||
A |
11354 |
Tablet 35mg-450mg 100 |
0.12 |
GM |
7,732 |
- |
|
A |
21041 |
Tablet 35mg-450mg 24 |
0.12 |
GM |
12,154 |
- |
|
OTHER CENTRALLY ACTING AGENTS |
|||||||
M03BX01 |
BACLOFEN |
||||||
P |
2729P |
Tablet 10mg |
50.00 |
MG |
107,146 |
3,543,243 |
|
P |
2730Q |
Tablet 25mg |
50.00 |
MG |
54,536 |
3,311,190 |
|
P |
6284R |
Intrathecal injection 10mg in 5mL 10 |
0.55 |
MG |
167 |
107,805 |
|
MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
|||||||
DANTROLENE AND DERIVATIVES |
|||||||
M03CA01 |
DANTROLENE SODIUM |
||||||
P |
1779P |
Capsule 25mg |
0.10 |
GM |
5,447 |
407,647 |
|
P |
1780Q |
Capsule 50mg |
0.10 |
GM |
2,524 |
211,939 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
MUSCULO-SKELETAL SYSTEM |
|||||||
M04AA01 |
ALLOPURINOL |
||||||
P |
2600W |
Tablet 100mg |
0.40 |
GM |
298,779 |
3,807,654 |
|
P |
2604C |
Tablet 300mg |
0.40 |
GM |
814,169 |
8,305,863 |
|
PREPARATIONS INCREASING URIC ACID EXCRETION |
|||||||
M04AB01 |
PROBENECID |
||||||
P |
1940D |
Tablet 500mg |
1.00 |
GM |
18,928 |
1,417,819 |
|
PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM |
|||||||
M04AC01 |
COLCHICINE |
||||||
P |
3410L |
Tablet 500ug 30 |
1.00 |
MG |
407,860 |
4,579,764 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
MUSCULO-SKELETAL SYSTEM |
|||||||
M05BA04 |
ALENDRONIC ACID |
||||||
P |
8090T |
Tablet 40mg |
10.00 |
MG |
11,133 |
1,233,712 |
|
P |
8511Y |
Tablet 70mg alendronic acid 4 |
10.00 |
MG |
566,106 |
22,273,005 |
|
M05BA02 |
CLODRONIC ACID |
||||||
P |
8132B |
Capsule equivalent to 400mg sodium clodronate |
1.60 |
GM |
635 |
218,040 |
|
P |
8265B |
Capsule equivalent to 800mg sodium clodronate |
1.60 |
GM |
10,289 |
4,023,804 |
|
M05BA01 |
DISODIUM ETIDRONATE |
||||||
P |
2920Q |
Tablet 200mg |
0.40 |
GM |
335 |
49,567 |
|
M05BA03 |
DISODIUM PAMIDRONATE |
||||||
P |
6223M |
Vial pdr for IV infuse 90mg amp solvent 10mL |
60.00 |
MG |
2,566 |
1,041,142 |
|
P |
6289B |
Concentrated injection 90mg in 10mL |
60.00 |
MG |
403 |
156,364 |
|
P |
8209C |
2 Vials pdr for IV infuse 30mg 2 amp solvent 10mL |
60.00 |
MG |
222 |
57,725 |
|
P |
8462J |
Concentrated injection 30mg in 10mL |
60.00 |
MG |
192 |
42,125 |
|
P |
8463K |
Concentrated injection 60mg in 10mL |
60.00 |
MG |
122 |
34,100 |
|
M05BA06 |
IBANDRONIC ACID |
||||||
P |
9357L |
Tablet 50mg (as ibandronate sodium monohydrate) 28 |
5.00 |
MG |
7,179 |
2,458,694 |
|
P |
9619G |
Inj for I.V. infusion equiv 6mg (as ibandronate sodium monohydrate) in 6mL |
6.00 |
MG |
1,399 |
519,486 |
|
M05BA07 |
RISEDRONIC ACID |
||||||
P |
4444X |
Tablet 35mg 4 |
5.00 |
MG |
1,670 |
80,649 |
|
P |
8481J |
Tablet 5mg 28 |
5.00 |
MG |
7,967 |
383,500 |
|
P |
8482K |
Tablet 30mg 28 |
5.00 |
MG |
2,914 |
789,281 |
|
P |
8621R |
Tablet 35mg |
5.00 |
MG |
307,687 |
14,821,966 |
|
P |
8972F |
Tablet 35mg (enteric coated) 4 |
5.00 |
MG |
35,478 |
1,647,400 |
|
P |
9391G |
Tablet 150mg 1 |
5.00 |
MG |
331,281 |
16,932,501 |
|
M05BA05 |
TILUDRONIC ACID |
||||||
P |
8267D |
Tablet 200mg |
0.40 |
MG |
488 |
148,655 |
|
M05BA08 |
ZOLEDRONIC ACID |
||||||
P |
6371H |
Injection concentrate I.V. infusion 4mg (as monohydrate) in 5mL |
4.00 |
MG |
22,355 |
11,521,908 |
|
P |
9288W |
Solution for I.V. infusion 5mg (as monohydrate) in 100mL |
0.01 |
MG |
27,537 |
16,213,056 |
|
P |
9350D |
Solution for I.V. infusion 5mg (as monohydrate) in 100mL |
0.01 |
MG |
880 |
517,607 |
|
BISPHOSPHONATES, COMBINATIONS |
|||||||
M05BB05 |
ALENDRONATE SODIUM with COLECALCIFEROL and CALCIUM CARBONATE |
||||||
P |
9351E |
Pack 4 tablets equiv 70mg alendronic acid with 140ug colecalciferol, 48 tablets calcium carbonate 1.25g |
10.00 |
MG |
235,622 |
10,631,507 |
|
M05BB03 |
ALENDRONIC ACID and COLECALCIFEROL |
||||||
P |
9012H |
Tablet equiv to 70mg alendronic with 70ug Colecal |
- |
- |
312,243 |
14,100,363 |
|
P |
9183H |
Tablet equiv to 70mg alendronic with 140ug Colecal |
- |
- |
439,522 |
19,843,357 |
|
M05BB01 |
ETIDRONIC ACID AND CALCIUM |
||||||
P |
8056B |
28 tabs 200mg and 76 tabs calcium (equiv 500mg) |
- |
- |
6,222 |
439,148 |
|
M05BB04 |
RISEDRONIC ACID and CALCIUM CARBONATE with COLECALCIFEROL |
||||||
P |
4380M |
4 tablets 35mg and 24 sachets granules 2.5g-22ug |
- |
- |
1,297 |
62,728 |
|
P |
8974H |
4 tablets 35mg and 24 sachets granules 2.5g-22ug |
- |
- |
39,378 |
1,829,574 |
|
P |
9147K |
4 tablets 35mg and 24 sachets granules 2.5g-22ug |
- |
- |
275,632 |
13,313,619 |
|
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
|||||||
M05BB02 |
RISEDRONIC SODIUM with CALCIUM CARBONATE |
||||||
P |
4059P |
Pack containing 4 tablets 35mg and 24 tabs 1.25g |
- |
- |
1,628 |
79,698 |
|
P |
8899J |
Pack containing 4 tablets 35mg and 24 tabs 1.25g |
- |
- |
373,806 |
18,053,356 |
|
P |
8973G |
Pack containing 4 tablets 35mg and 24 tabs 1.25g |
- |
- |
36,324 |
1,687,086 |
|
OTHER DRUGS AFFECTING BONE STRUCTURE |
|||||||
M05BX04 |
DENOSUMAB |
||||||
P |
5110Y |
Injection 120mg in 1.7ml 1 |
0.33 |
MG |
302 |
160,374 |
|
P |
5457F |
Injection 60mg in 1 ml prefilled syringe |
0.33 |
MG |
13,454 |
4,103,294 |
|
M05BX03 |
STRONTIUM RANELATE |
||||||
P |
3036T |
Granules for oral suspension 2g, 28 Sachets |
2.00 |
GM |
336,269 |
17,904,218 |